U.S. Markets
Eli Lilly (LLY) has signed a deal with AI startup profluent worth up to USD 2.25bln to find new ways to edit DNA
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
